Viewing Study NCT02638805


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2026-01-17 @ 11:10 PM
Study NCT ID: NCT02638805
Status: COMPLETED
Last Update Posted: 2018-11-05
First Post: 2015-12-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
Sponsor: Intarcia Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module